GGI
KYTX icon

GordonMD Global Investments’s Kyverna Therapeutics KYTX Stock Holding History

GordonMD Global Investments’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36.6M Sell
4,244,818
-147,000
-3% -$1.22M 25.51% 1
2025
Q4 		$41.3M Buy
+4,391,818
New +$32.6M 29.6% 1

Other funds holding KYTX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GordonMD Global Investments's KYTX Position: Q1 2026 in Review

GordonMD Global Investments reduced its Kyverna Therapeutics (KYTX) stake by 3.3% in Q1 2026, selling an estimated $1.22M and leaving 4,244,818 shares worth $36.6M. The position accounts for 25.51% of the portfolio, ranked #1.

GordonMD Global Investments first reported a position in KYTX in Q4 2025 and has held it in 2 quarters since. The position peaked at $41.3M in Q4 2025. 111 funds tracked by Wall St. Rank hold KYTX as of Q1 2026.

  • GordonMD Global Investments held 4,244,818 shares of Kyverna Therapeutics worth $36.6M as of Q1 2026.
  • GordonMD Global Investments sold 147,000 Kyverna Therapeutics shares in Q1 2026, an estimated $1.22M.
  • Kyverna Therapeutics made up 25.51% of GordonMD Global Investments's portfolio in Q1 2026, its #1 holding.
  • GordonMD Global Investments first reported a position in Kyverna Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • GordonMD Global Investments's Kyverna Therapeutics position peaked at $41.3M in Q4 2025.
  • 111 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q1 2026.

Based on GordonMD Global Investments's 13F filing for Q1 2026, filed 15 May 2026.